Difference between revisions of "Avatrombopag (Doptelet)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
m (Text replacement - "Category:Autoimmune thrombocytopenic purpura" to "Category:Immune thrombocytopenia")
Line 3: Line 3:
  
 
==Diseases for which it is used==
 
==Diseases for which it is used==
*[[Autoimmune thrombocytopenic purpura (ITP)]]
+
*[[Immune thrombocytopenia (ITP)]]
 
# Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. [http://bloodjournal.hematologylibrary.org/content/123/25/3887.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24802775 PubMed]
 
# Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. [http://bloodjournal.hematologylibrary.org/content/123/25/3887.long link to original article] [https://www.ncbi.nlm.nih.gov/pubmed/24802775 PubMed]
 
*[[Thrombocytopenia in liver disease]]
 
*[[Thrombocytopenia in liver disease]]

Revision as of 01:51, 24 July 2018

Mechanism of action

Thrombopoietin receptor agonist

Diseases for which it is used

  1. Bussel JB, Kuter DJ, Aledort LM, Kessler CM, Cuker A, Pendergrass KB, Tang S, McIntosh J. A randomized trial of avatrombopag, an investigational thrombopoietin-receptor agonist, in persistent and chronic immune thrombocytopenia. Blood. 2014 Jun 19;123(25):3887-94. Epub 2014 May 6. link to original article PubMed

History of changes in FDA indication

Also known as

  • Code names: E5501, YM477, AKR 501
  • Brand name: Doptelet